Blood Cancer Talks

1.     Phase III ASAP trial
https://ash.confex.com/ash/2022/webprogram/Paper159962.html
 
 
2.     Phase III Dauno-Double Trial
https://ash.confex.com/ash/2022/webprogram/Paper157126.html
 
 
3.     Reduced venetoclax exposure: 
https://ash.confex.com/ash/2022/webprogram/Paper165464.html
 
 
4.    Menin Inhibitors in AML 
https://ash.confex.com/ash/2022/webprogram/Paper164849.html
https://ash.confex.com/ash/2022/webprogram/Paper167412.html
 
 
5.    Imetelstat in MDS: IMerge Phase 2
https://ash.confex.com/ash/2022/webprogram/Paper169050.html
 
 
6.    MOMENTUM: Momelotinib
https://ash.confex.com/ash/2022/webprogram/Paper162783.html

How I manage anemia related to myelofibrosis and its treatment regimens

 https://link.springer.com/article/10.1007/s00277-023-05126-4



What is Blood Cancer Talks?

This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth.
Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston
Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk